Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

A Life Sciences Project Accelerator Kicks into High Gear

XPhyto Therapeutics Corp. ( CSE: XPHY ) (FSE: 4XT) (OTC: XPHYF) has been a hot story lately, especially in Germany, due to its recent commercialization of a super-fast PCR test kit for definitively diagnosing COVID-19 infections in point-of-care settings. The company rec...
Marc Davis | May 10, 2021 |

Why A Multi-Billion-Dollar Diamond Discovery Looms Large

The discovery of Canada’s next multi-billion-dollar diamond deposit is long overdue. Truth be told, a truly big, world-class diamond discovery has not been made in Canada since the 90s. However, there has been a renewed push in recent years to unlock the ge...
Marc Davis | February 25, 2019 |

ConocoPhillips (COP): Playing the crack spread

There’s a lot of talk about diversification and asset allocation on this website, and rightly so. While diversification can limit large short-term gains, it also protects against large short-term losses. Since the markets tend to be unpredictable, it&CloseC...
Justin Dove | October 28, 2012 |

Multi-billion dollar valuation set for dynaCERT Inc. (V.DYA), pieces falling into place

dynaCERT Inc. (TSX VENTURE: DYA) (OTCQB: DYFSF) (FRA: DMJ) this week announced it has received its European ABE (German for “permit of operation”) certification for the Company’s HydraGEN™ (HG) Carbon Emission Reduction Technology fo...
James O'Rourke | August 27, 2019 |

dynaCERT first institutional coverage; >250% near-term upside, no competition in $6 Trillion market

dynaCERT’s Fuel-Saving and Carbon Emission Reduction Technology is award winning and on an accelerated growth adoption curve that is expected to translate into significant sales and upside share price revaluation. dynaCERT's proprietary HG technology has ...
Fredrick William | September 24, 2019 |

dynaCERT attracting major strategic investors entering 2020, exponential growth potential

Order of Canada member Eric Sprott, plus Dr. Jorg Mosolf (of Europe’s MOSOLF Group) are two of the most recent strategic investors that have taken significant shareholder positions and made business commitments in DYA.V. dynaCERT is at the forefront of t...
James O'Rourke | December 31, 2019 |

BlackRock CEO says climate crisis will reshape finance, DynaCERT approaches escape velocity

631 investors from around the world, representing ~US$37 trillion in assets, signed a letter in December urging governments to step up their efforts against climate change. This letter put pressure on major asset managers to articulate strategies around sustainability. ...
Fredrick William | February 18, 2020 |

dynaCERT Invited to Speak at World Climate Summit on Future of World Carbon Credits, ...

dynaCERT Invited to Speak at World Climate Summit on Future of World Carbon Credits, Sales Growing Exponentially dynaCERT Inc. (TSX-V: DYA) (OTCQB: DYFSF) (Frankfurt: DMJ) CEO & President, Jim Payne, was interviewed on Bloomberg BNN (Business News Network) this week in...
James O'Rourke | February 28, 2020 |

XPhyto Therapeutics: Are they Selling the Solution to Germany’s Rapid Testing Crisis?

The Germans call it COVID-19 “rapid testing mania”. But like most manias, it has opened up a Pandora’s box of problems. As the speed of the vaccine rollout program falters in Europe, on-the-spot antigen testing continues to be the ...
Marc Davis | June 2, 2021 |

Covid-19: Who, what, when, where and why

If there is one thing we know about the coronavirus, it’s that getting a jump on it helps to limit the number of infections. Clearly the best time to stop this, and all outbreaks, is in its early stages. Both China and the United States have been accused of...
Richard (Rick) Mills | April 13, 2020 |
1 2 3 4 5 6 7 8 9 10 ...